Sundial Growers Inc. (NASDAQ: SNDL) ("Sundial" or the "Company") reported its financial and operational results for the third quarter ended September 30, 2021. All financial information in this press release is reported in millions of Canadian dollars and represents results from continuing operations, unless otherwise indicated.
The Company will hold a conference call and webcast at 10:30 a.m. EST (8:30 a.m. MST) on Friday, November 12, 2021. Please see the dial-in details within the release, as well as additional details on Sundial's website at www.sndlgroup.com.
THIRD QUARTER 2021 OPERATIONAL AND INVESTMENT HIGHLIGHTS
"Our third quarter results reflect the initial impact of the business transformation led by Sundial's team over the last 10 months," said Zach George, Chief Executive Officer of Sundial. "We remain focused on sustainable profitability and continued improvement in all aspects of our operations. Despite the ongoing challenges facing industry participants, our financial condition has never been stronger. Sundial is uniquely positioned relative to its peers as we seek to delight consumers and become a trusted industry partner. Our balance sheet strength enables our team to avoid short term pressures while working to improve the quality of our decision making. We expect that the achievement of our objectives will result in an aggregate base business that generates free cash flow in 2022."
THIRD QUARTER 2021 KEY FINANCIAL METRICS
OPERATING SEGMENTS | ---------Cannabis--------- | |||||||||
($000s) | Cultivation | Retail | Investment | Corporate | Total | |||||
As at September 30, 2021 | ||||||||||
Total assets | 174,578 | 166,955 | 1,109,840 | 2,998 | 1,454,371 | |||||
Nine months ended September 30, 2021 | ||||||||||
Net revenue | 27,269 | 6,140 | 6,756 | — | 40,165 | |||||
Gross margin | (8,149) | 3,658 | 6,756 | — | 2,265 | |||||
Share of profit of equity-accounted investees | — | — | 13,642 | — | 13,642 | |||||
Depreciation and amortization | 2,442 | 1,463 | — | 469 | 4,374 | |||||
Earnings (loss) before tax | (94,800) | (476) | 17,339 | (107,542) | (185,479) | |||||
Three months ended September 30, 2021 | ||||||||||
Net revenue | 8,227 | 6,140 | (14,699) | — | (332) | |||||
Gross margin | (1,876) | 3,658 | (14,699) | — | (12,917) | |||||
Share of profit of equity-accounted investees | — | — | 9,918 | — | 9,918 | |||||
Depreciation and amortization | 660 | 1,463 | — | 262 | 2,385 | |||||
Earnings (loss) before tax | (10,177) | (476) | (6,012) | 17,918 | 1,253 |
Sundial reports three operating segments including two Cannabis segments: Cultivation and production, and retail, which was added with the acquisition of Inner Spirit. The third segment is Investments. For the three and nine months ended September 30, 2020, Cannabis was the only reportable segment, and therefore no comparative segment information is available for the Investment or retail segments.
ALCANNA ACQUISITION
On October 7, 2021, the Company announced that it had entered into an arrangement agreement with Alcanna pursuant to which the Company will acquire all of the issued and outstanding common shares of Alcanna by way of a statutory plan of arrangement for total consideration of 387.3 million common shares of Sundial, with a value of approximately $346 million (the "Alcanna Acquisition"). The Alcanna Acquisition is expected to close in the fourth quarter of 2021, subject to customary closing conditions. Alcanna's longstanding liquor business provides Sundial with stable cash generation through a mature and proven business model with trailing twelve months free cash flow of $16.4 million on a built-out retail platform.
Alcanna is a Canadian liquor retailer, operating predominantly in Alberta under its three retail brands, "Wine and Beyond", "Liquor Depot" and "Ace Liquor". Alcanna also holds an approximate 63% equity interest in Nova Cannabis Inc., a Canadian cannabis retailer operating stores across Alberta, Saskatchewan, and Ontario.
THIRD QUARTER 2021 RESULTS
CANNABIS RESULTS
The Company's Cannabis operations are comprised of two segments: cannabis cultivation and production and, with the acquisition of Inner Spirit, cannabis retail.
CANNABIS CULTIVATION AND PRODUCTION
Sundial remains focused and committed to optimization of its cultivation and processing activities.
GROSS MARGIN BEFORE FAIR VALUE ADJUSTMENTS
Gross margin before fair value adjustments from cannabis cultivation and production for the three months ended September 30, 2021 was negative $4.9 million compared to negative $17.3 million for the three months ended September 30, 2020. The increase of $12.4 million was due to a lower inventory obsolescence provision compared to the prior period as well as Sundial's ongoing focus on cost optimization, reduction of harvest inventory subject to impairment and offering the most competitive and profitable strains and brands to its customers against the backdrop of industry-wide price compression and high relative operating costs at our premium facility.
NET REVENUE FROM CULTIVATION AND PRODUCTION
Net revenue from cultivation and production operations in the third quarter of 2021 was $8.2 million compared to $12.9 million in the third quarter of 2020, reflecting the Company's continuing shift to branded sales from wholesales.
GROSS SELLING PRICE
Average gross selling price was $3.23 per gram in the third quarter of 2021, compared to $2.67 per gram in the third quarter of 2020. The increase of $0.56 per gram equivalent was mainly due to an increase in prices for sales to other LPs, partially offset by lower prices for provincial board sales. Average gross selling price per gram equivalent of branded products, net of provisions, was $3.31 per gram in the third quarter of 2021, compared to $3.19 per gram in the second quarter of 2021.
REVENUE BY FORMATS
In the third quarter of 2021 gross revenue from Sundial's formats was:
Three months ended September 30 | Nine months ended September 30 | ||||||||||
($000s) | 2021 | 2020 | 2021 | 2020 | |||||||
Revenue from dried flower | 9,273 | 11,629 | 28,763 | 39,443 | |||||||
Revenue from vapes | 1,166 | 3,577 | 3,863 | 14,185 | |||||||
Revenue from oil | 37 | 319 | 1,628 | 2,828 | |||||||
Revenue from edibles and concentrates | 546 | — | 1,255 | — | |||||||
Gross revenue | 11,022 | 15,525 | 35,509 | 56,456 |
As the cannabis industry continues to be faced by challenges and price compression in all segments, Sundial's revenue by formats for the third quarter of 2021 has declined compared to the third quarter of 2020. Due to a purposeful portfolio rationalization in Sundial's vape segment along with continued price pressure, Sundial has seen a decrease in gross revenue in the third quarter of 2021.
CANNABIS RETAIL
Sundial completed its acquisition of Inner Spirit on July 20, 2021. As a result, this is the first quarter that the Company's consolidated financial results include Inner Spirit.
1 System-wide retail sales is a non-IFRS financial measure. For more details, see the "Non-IFRS Financial Measures" section below. |
GROSS MARGIN
Gross margin for the period July 20 to September 30, 2021, was $3.7 million.
INVESTMENTS
Sundial's investment income is classified as income from operations.
REVENUE FROM INVESTMENTS
Revenue from Investments in the third quarter of 2021 was negative $4.8 million including unrealized losses on marketable securities, due to fluctuation in share prices from our portfolio of investments.
Three months ended September 30 | Nine months ended September 30 | ||||||||
($000s) | 2021 | 2020 | 2021 | 2020 | |||||
Interest and fee revenue | |||||||||
Interest revenue from investments at amortized cost | 352 | — | 793 | — | |||||
Interest and fee revenue from investments at Fair Value Through Profit or Loss | 2,116 | — | 6,398 | — | |||||
Interest revenue from cash | 841 | — | 2,311 | — | |||||
3,309 | — | 9,502 | — | ||||||
Investment revenue | |||||||||
Realized gains | 5,988 | — | 18,218 | — | |||||
Unrealized gains (losses) | (23,996) | — | (20,964) | — | |||||
(18,008) | — | (2,746) | — | ||||||
Revenue from direct investments | (14,699) | — | 6,756 | — | |||||
Share of profit of equity-accounted investees | 9,918 | — | 13,642 | — | |||||
Total investment activities | (4,781) | — | 20,398 | — |
CONSOLIDATED FINANCIAL RESULTS
SALES, MARKETING AND GENERAL AND ADMINISTRATIVE EXPENSES
SMG&A costs increased by 30% from $8.3 million to $10.8 million in the third quarter of 2021 when compared to the third quarter of 2020. The increase was mainly due to increased employee-related costs, and inclusion of Spiritleaf results subsequent to its acquisition.
NET EARNINGS
Net earnings for the three months ended September 30, 2021 were $11.3 million compared to a net loss of $71.4 million in the previous year.
ADJUSTED EBITDA FROM CONTINUING OPERATIONS
Adjusted EBITDA from continuing operations was $10.5 million for the three months ended September 30, 2021 compared to a loss of $4.4 million for the three months ended September 30, 2020.2 The increase was due to the following:
2 Adjusted EBIDTA is a non-IFRS financial measures. For more details, see the "Non-IFRS Financial Measures" section below. |
STRATEGIC AND ORGANIZATIONAL UPDATE
Sundial remains focused on building long-term shareholder value through the accretive deployment of cash resources and on achieving sustainable profitability through a streamlined and right-sized operating structure, and on enhanced offering of high-quality brands.
CANNABIS
INVESTMENTS
COVID-19 UPDATE
The Company continues to monitor daily developments in the COVID-19 pandemic and actions taken by government authorities. In accordance with the guidance of provincial and federal health officials to limit the risk and transmission of COVID-19, Sundial continues to implement mandatory self-quarantine policies, travel restrictions, enhanced cleaning and sanitation processes and frequency, safety shields at its retail outlets and social distancing measures. Sundial believes that it has maintained and can maintain safe operations with these pandemic-related procedures and protocols in place. The Company has not experienced a material impact on its production and processing activities to date related to COVID-19.
NON-IFRS MEASURES
Certain financial measures in this news release, including adjusted EBITDA from continuing operations, gross margin before fair value adjustments, and system-wide retail sales are non-IFRS measures. These terms are not defined by IFRS and, therefore, may not be comparable to similar measures provided by other companies. These non-IFRS financial measures should not be considered in isolation or as an alternative for measures of performance prepared in accordance with IFRS.
ADJUSTED EBITDA FROM CONTINUING OPERATIONS
Adjusted EBITDA from continuing operations is a non-IFRS measure which the Company uses to evaluate its operating performance. Adjusted EBITDA from continuing operations provides information to investors, analysts and others to aid in understanding and evaluating the Company's operating results in a similar manner to its management team. Adjusted EBITDA from continuing operations is defined as net income (loss) from continuing operations before finance costs, depreciation and amortization, accretion expense, income tax recovery and excluding change in fair value of biological assets, change in fair value realized through inventory, unrealized foreign exchange gains or losses, unrealized gains or losses on marketable securities, change in fair value of derivative warrants, share-based compensation expense, asset impairment, gain or loss on disposal of property, plant and equipment and certain one-time non-operating expenses, as determined by management.
($000s except percentages) | Q3 2021 | Q2 2021 | % Change | Q3 2020 | % Change | ||
Net income (loss) from continuing operations | 11,311 | (52,287) | 122% | (71,397) | 116% | ||
Adjustments | |||||||
Finance costs | 135 | 40 | 238% | (8,139) | 102% | ||
Change in estimate of fair value of derivative warrants | (24,100) | (19,810) | -22% | (10,058) | -140% | ||
Depreciation and amortization | 2,385 | 931 | 156% | 1,480 | 61% | ||
Income tax recovery | (10,058) | — | 100% | — | 100% | ||
Change in fair value of biological assets | (2,975) | 331 | 999% | (194) | -1434% | ||
Change in fair value realized through inventory | (15) | 456 | 103% | 2,447 | 101% | ||
Unrealized foreign exchange (gain) loss | (2,071) | 104 | 2091% | (243) | -752% | ||
Unrealized (gain) loss on marketable securities | 23,996 | 1,849 | 1198% | — | 100% | ||
Share-based compensation | 1,869 | 4,539 | -59% | 3,118 | -40% | ||
Asset impairment | — | 60,000 | -100% | 60,000 | -100% | ||
Loss (gain) on disposition of PP&E | — | 22 | -100% | — | 0% | ||
Cost of sales non-cash component (1) | 915 | 1,162 | -21% | 1,289 | -29% | ||
Inventory obsolescence | 3,871 | 1,651 | 134% | 19,897 | -81% | ||
Restructuring costs | — | — | 0% | 1,108 | -100% | ||
Transaction costs (2) | 5,276 | 805 | 555% | 364 | 1349% | ||
Government subsidies | — | — | 0% | (4,081) | -100% | ||
Other expenses | — | 2 | -100% | — | 0% | ||
Adjusted EBITDA from continuing operations | 10,539 | (205) | 5241% | (4,409) | 339% | ||
(1) Cost of sales non-cash component is comprised of depreciation expense | |||||||
(2) Transaction costs relate to financing activities |
($000s except percentages) | YTD 2021 | YTD 2020 | % Change |
Net loss from continuing operations | (175,421) | (142,173) | -23% |
Adjustments | |||
Finance costs | 226 | (1,155) | 120% |
Change in estimate of fair value of derivative warrants | 86,034 | (10,469) | 922% |
Depreciation and amortization | 4,374 | 3,414 | 28% |
Income tax recovery | (10,058) | — | 100% |
Change in fair value of biological assets | (2,550) | (4,853) | 47% |
Change in fair value realized through inventory | 491 | 18,352 | -97% |
Unrealized foreign exchange (gain) loss | (62) | (1,429) | 96% |
Unrealized (gain) loss on marketable securities | 20,964 | — | 100% |
Share-based compensation | 9,864 | 7,065 | 40% |
Asset impairment | 60,000 | 65,659 | -9% |
Loss (gain) on disposition of PP&E | 139 | (488) | 128% |
Cost of sales non-cash component (1) | 2,903 | 3,618 | -20% |
Inventory obsolescence | 7,276 | 37,638 | -81% |
Restructuring costs | — | 6,190 | -100% |
Transaction costs (2) | 9,729 | 2,762 | 252% |
Government subsidies | (2,180) | (4,081) | 47% |
Other expenses | 1,932 | — | 100% |
Adjusted EBITDA from continuing operations | 13,661 | (19,950) | 168% |
(1) Cost of sales non-cash component is comprised of depreciation expense | |||
(2) Transaction costs relate to financing activities |
SYSTEM-WIDE RETAIL SALES
System-wide retail sales is a non-IFRS measure which the Company uses to evaluate the performance of its retail operations. System-wide retail sales represent the aggregate revenue earned by franchised Spiritleaf retail cannabis stores and corporate-owned Spiritleaf retail cannabis stores, and do not represent revenues that accrue to the Company. The Company receives all revenues from corporate-owned Spiritleaf retail cannabis stores, as well as royalties and advertising fees in respect of the franchised Spiritleaf retail cannabis store revenue forming part of the system-wide retail sales.
Three months ended September 30 | ||||||
($000s) | 2021 | |||||
Gross revenue | 6,140 | |||||
Less: | ||||||
Royalties | 1,684 | |||||
Advertising | 371 | |||||
Millwork | 212 | |||||
Franchise fee | 142 | |||||
Supply | 446 | |||||
Add back: | ||||||
Franchise store sales | 30,264 | |||||
System-wide retail sales (1) | 33,549 |
CONFERENCE CALL
Sundial will host a conference call and webcast at 10:30 a.m. EST (8:30 a.m. MST) on Friday, November 12, 2021. A current investor presentation will be available on http://sndlgroup.com/investors.
WEBCAST ACCESS
To access the live webcast of the call, please visit the following link:
http://services.choruscall.ca/links/sundialgrowers20211112.html
REPLAY
The webcast archive will be available for three months via the link provided above.
A telephone replay will be available for one month. To access the replay dial:
Canada/USA Toll Free: 1-800-319-6413 or International Toll: +1-604-638-9010
When prompted, enter Replay Access Code: 8057#
ABOUT SUNDIAL GROWERS INC.
Sundial is a public company with Common Shares traded on Nasdaq under the symbol "SNDL". Our business is reported and analyzed under three operating segments: Cannabis Operations, Cannabis Retail and Investments.
As a licensed producer that crafts small-batch cannabis using state-of-the-art indoor facilities, our 'craft-at-scale' modular growing approach, award-winning genetics and experienced growers set us apart. Sundial's brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Sundial also operates the Spiritleaf retail banner. Spiritleaf aims to be the most knowledgeable and trusted source of recreational cannabis by offering a premium consumer experience and quality curated cannabis products.
Our investment operations seek to deploy strategic capital through direct and indirect investments and partnerships throughout the global cannabis industry.
We are proudly Albertan, headquartered in Calgary, AB, with operations in Olds and Rocky View County, Alberta, Canada. For more information on Sundial, please go to www.sndlgroup.com.
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"), including, but not limited to, statements regarding the Company's cost-cutting initiatives, the cost savings expected to be achieved, operational goals, demand for the Company's products, the Company's ability to achieve profitability, the development of the legal cannabis market, performance of the Company's investments and the maintenance of production levels, including during the COVID-19 pandemic. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "likely", "outlook", "forecast", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Please see "Item 3D Risk Factors" in the Company's Annual Report on Form 20-F, which was filed with the Securities and Exchange Commission ("SEC") on March 17, 2021, and the risk factors included in our other SEC filings for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Last Trade: | US$1.98 |
Daily Change: | 0.02 1.02 |
Daily Volume: | 3,003,407 |
Market Cap: | US$524.860M |
November 05, 2024 |
Surf Air Mobility is a regional air mobility platform expanding the category of regional air travel to reinvent flying through the power of electrification. In an effort to substantially reduce the cost and environmental impact of...
CLICK TO LEARN MOREElse Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS